MedPath

Algiax Pharmaceuticals GmbH

Algiax Pharmaceuticals GmbH logo
🇩🇪Germany
Ownership
Holding
Established
2011-01-01
Employees
1
Market Cap
-
Website
http://www.algiax.com

Clinical Trials

4

Active:3
Completed:1

Trial Phases

2 Phases

Phase 1:3
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (75.0%)
Phase 2
1 (25.0%)

AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

Phase 2
Completed
Conditions
Peripheral Post-surgical Neuropathic Pain
Interventions
Drug: Placebo
First Posted Date
2020-06-12
Last Posted Date
2024-10-16
Lead Sponsor
Algiax Pharmaceuticals GmbH
Target Recruit Count
99
Registration Number
NCT04429919
Locations
🇧🇪

UZ Antwerp, Edegem, Belgium

🇧🇪

Ziekenhuis Oost Limburg - campus St. Jan, Genk, Belgium

🇧🇪

AZ Sint-Lucas, Pijnkliniek, Gent, Belgium

and more 29 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.